Skip to main content

Table 2 Characteristics of the patients

From: Comparisons of six endoscopy independent scoring systems for the prediction of clinical outcomes for elderly and younger patients with upper gastrointestinal bleeding

Variables Elderly patients Younger patients P-value (p < 0.05)
Age 72.9 \(\pm\) 6.1 48.7 \(\pm\) 12.2
Sex (male/female) 350:180 573:157  < 0.01
Comorbidity    
 Cirrhosis 52 (9.8%) 108(14.8%)  < 0.01
 Renal failure 56 (10.6%) 10(1.4%)  < 0.01
 Any malignancy 46 (8.7%) 118(16.2%)  < 0.01
 PCI 52 (9.8%) 28(3.8%)  < 0.01
 Heart failure 16 (3.0%) 2(0.3%)  < 0.01
 Hypertension 294 (55.5%) 212(29%)  < 0.01
 Diabetes 102 (19.2%) 90(12.3%)  < 0.01
 Chronic lung disease 18 (3.4%) 2(0.3%)  < 0.01
Medications    
 NSAIDs 6 (1.1%) 4(0.5%)  > 0.05
 Aspirin 130 (24.5%) 62(8.5%)  < 0.01
 Clopidogrel 64 (12.1%) 20(2.7%)  < 0.01
 Oral anticoagulants 22 (4.2%) 4(0.5%)  < 0.01
 Steroids 8 (1.5%) 6(0.8%)  > 0.05
Relevant variables and scores components (median (IQR))    
 Systolic blood pressure(mmHg) 124(28) 120(24)
 Pulse(beats/min) 79(18) 82(22.5)
 Creatinine(μmol/L) 82(41) 73(27)
 Hemoglobin(g/L) 89(43) 102.5(45)
 Albumin (g/L) 33.7(8.45) 37.25(9.08)
 Urea(mmol/L) 9.7(10.1) 7.9(6.35)
 ASA score 3(1) 2(2)
Findings at endoscopy    
 Duodenal/gastric ulcer 246 (46.4%) 424(58%)  < 0.01
 Erosions 44 (8.3%) 56(7.7%)  > 0.05
 Upper GI cancer 70 (13.2%) 28(3.8%)  < 0.01
 Variceal bleeding 44 (8.3%) 88(12.1%)  < 0.05
 Esophagitis 16 (3.0%) 10(1.4%)  < 0.05
 Mallory-Weiss syndrome 16 (3.0%) 32(4.4%)  > 0.05
 Normal 94(16.9%) 92(12.3%)  < 0.05
Outcomes    
 Death (total) 44 (8.3%) 24(3.3%)  < 0.01
 Intervention 240 (45.3%) 304 (41.6%)  > 0.05
 Rebleeding 112 (21.1%) 60 (8.2%)  < 0.01
  1. PCI percutaneous coronary intervention, NSAIDs nonsteroidal anti-inflammatory drugs, IQR interquartile range